different kinds of cryptocurrencies

Guan Qingyou: I am optimistic about the stock market by cutting interest rates and lowering the RRR. For example, Guan Qingyou, president and chief economist of the Financial Research Institute, said that lowering the RRR and raising interest rates will definitely happen, and from the downward trend of previous interest rates, it should be faster. Regarding the current market conditions, Guan Qingyou said that different subjects have different judgments on the market trend in one or two trading days, but he is still optimistic, and said that the positive impact of the current policy change on the capital market cannot be underestimated. Combining industrial structure and policy orientation, Guan Qingyou said that consumer companies, technology companies, and mergers and acquisitions involving the transformation and upgrading of traditional industries to emerging formats are all his optimistic directions. In addition, for the economic growth target in 2025, Guan Qingyou believes that "the target of 5% can still be contested". He also said that 2025 will be better than 2024. "In 2025, the adjustment of policies will bring more increments to the market and industry." (sohu finance)The Baltic dry bulk freight index fell 4.61% to 1055 points.Analyst: The interest rate of the European Central Bank will be pushed to the low end of the neutral range. Marchel Alexandrovich, an economist at Saltmarsh Economics, said that the European Central Bank cut interest rates by 25 basis points again, which is the fourth time in this easing cycle. The monetary policy statement reiterated that the Committee would not commit to a specific interest rate path in advance. However, the new forecast shows that the core inflation rate is 1.9% in 2026 and 2027, which indicates that interest rates may continue to push to the low end of the neutral range.

The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Leshan Guotou Group and others set up an industrial guidance equity investment fund with a capital contribution of 4.5 billion yuan. According to Tianyancha App, recently, Leshan Jiarong Industrial Guidance Equity Investment Fund Partnership (Limited Partnership) was established, and the executive partner is Leshan Guorong Equity Investment Fund Management Co., Ltd., with a capital contribution of 4.5 billion yuan, and its business scope includes investment activities with its own funds. According to the partner information, the fund is jointly funded by Leshan State-owned Assets Investment and Operation (Group) Co., Ltd., Leshan Finance Bureau and Leshan Guorong Equity Investment Fund Management Co., Ltd.The Nikkei 225 index just broke through the 40000.00 mark, and the latest report was 40000.43, up 1.60% in the day.

As of December 6, 2024, Pakistan's foreign exchange reserves were $12.1 billion.The Nikkei 225 index just broke through the 40000.00 mark, and the latest report was 40000.43, up 1.60% in the day.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).